Home › Research › Cognitive tests and assessment
Effect of glycosylated hemoglobin on cognitive impairment related to White Matter Hyperintensity in non diabetes patients: A retrospective study
Xu L, Tong Q, Ye H.. Research Square, 2026-08-12
Topic: Brain imaging, connectivity and assessment
Plain-language summary
Background White Matter Hyperintensity (WMH) are closely related to cognitive decline. Cognitive decline is a prolonged process preceding the onset of dementia, identifying relevant associated factors helps facilitate early intervention and long-term prognosis. This study aimed to explore the effect of glycated hemoglobin (HbA1c) and cognitive impairment in non diabetes people with WMH. Methods A total of 497 non diabetes patients with WMH were enrolled. Montreal Cognitive Assessment Basic (MoCA-BC) was used to assessed cognitive function. Fasting venous blood samples were collected to test HbA1c levels. WMH severity was graded using the Age-Related White Matter Changes Rating Scale (ARWMC). Univariate and multivariate logistic regression as well as restricted cubic spline (RCS) analyses were performed to explore the correlation between HbA1c and cognitive impairment. Receiver operating characteristic (ROC) curve analysis was used to assess the discriminative ability of HbA1c for cognitive impairment in non diabetes patients with WMH. Results HbA1c levels were significantly associated with cognitive impairment (P < 0.001), and this correlation remained significant after adjustment for multiple covariates (P < 0.001). A significant nonlinear correlation was also detected between HbA1c and cognitive impairment (P < 0.001). ROC analysis showed that HbA1c exhibited good discriminative ability for cognitive impairment, with an area under the curve (AUC) of 0.813 (95% CI: 0.773–0.853, P < 0.001). Conclusions HbA1c levels had warning value for cognitive impairment in non diabetes patients with WMH, and a nonlinear correlation exists between HbA1c and WMH-related cognitive impairment.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Xu, L., Tong, Q., & Ye, H. (2026). Effect of glycosylated hemoglobin on cognitive impairment related to White Matter Hyperintensity in non diabetes patients: A retrospective study. Research Square. https://doi.org/10.21203/rs.3.rs-10279428/v1
Vancouver
Xu L, Tong Q, Ye H. Effect of glycosylated hemoglobin on cognitive impairment related to White Matter Hyperintensity in non diabetes patients: A retrospective study. Research Square. 2026. doi:10.21203/rs.3.rs-10279428/v1.
BibTeX
@article{xu2026-764c772a,
author = {Xu, L. and Tong, Q. and Ye, H.},
title = {{Effect of glycosylated hemoglobin on cognitive impairment related to White Matter Hyperintensity in non diabetes patients: A retrospective study}},
journal = {Research Square},
year = {2026},
doi = {10.21203/rs.3.rs-10279428/v1},
url = {https://doi.org/10.21203/rs.3.rs-10279428/v1}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Results HbA1c levels were significantly associated with cognitive impairment (P < 0.001), and this correlation remained significant after adjustment for multiple covariates (P < 0.001).
- A significant nonlinear correlation was also detected between HbA1c and cognitive impairment (P < 0.001).
- ROC analysis showed that HbA1c exhibited good discriminative ability for cognitive impairment, with an area under the curve (AUC) of 0.813 (95% CI: 0.773–0.853, P < 0.001).
Study details
- Participants497
- Evidence strengthLow
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 29 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 18 of the 62 points we could judge it on, which is 29 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (Research Square) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 2 / 4 | 497 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 18 / 62 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 18 of the 62 points we could judge it on is 29 out of 100. |
| Total | 29 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Cognitive tests and assessment from nearby years
Also tagged “metabolic-syndrome”
305 studies in the library carry the topic tag “metabolic-syndrome”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 305 tagged studies.